This Week in Psychedelics - 10.2.20

Cannabis

• FBI: Marijuana Arrests Decline Year-Over-Year, But Still Outpace Arrests for All Violent Crimes (NORML)

• Colorado Governor Grants Thousands Of Marijuana Pardons With New Clemency Powers (Marijuana Moment)

• New Jersey: Lawmakers Approve Telemedicine for Medical Cannabis Authorizations (NORML)

• Hawaii: Governor Legalizes Sales of Edible Products by Licensed Medical Cannabis Dispensaries (NORML)

• Democrats Remove Marijuana Research Bill From House Floor Schedule After Briefly Listing Possible Vote (Marijuana Moment)

• Michigan: Lawmakers Approve Marijuana Expungement Legislation (NORML)

• Where President Donald Trump Stands On Marijuana (Marijuana Moment)

• New Jersey: Voter Support Solidly in Favor of Marijuana Legalization Ahead of Ballot Initiative Vote (NORML)

• Study: Nearly Thirty Percent of Women Report Having Used Cannabis for Menopause Symptoms (NORML)

LSD

• LSD, Music, and the Mysteries of Consciousness (Psychedelic Science Review)

• Crystal Structure of LSD & 5-HT2AR- Part 1: Capturing the First Steps of a Psychedelic Trip (Psychedelic Science Review)

Magic Mushrooms

• Oregon Psilocybin Initiative Gets Boost From New TV Ad But Draws Opposition From Unlikely Source (Marijuana Moment)

• Psygen Labs To Supply NeonMind With Psilocybin For Weight Loss Study (Green Market Report)

• Denver Mushroom Dealer Pleads Guilty in Federal Court (Westword)

• Psilocybin Patents: Predictors and Drivers of Company Value? (Psilocybin Alpha)

MDMA

• ATAI Life Sciences Company, EmpathBio, Dives Into MDMA Derivatives, Calls MAPS’ Approach “MDMA 1.0” (Psymposia)

• LGBTQIA Providers and Participants in MDMA Clinical Trials with Terence Ching (Chacruna)

DMT

• Combatting resistant depression with DMT and digital therapy (Health Europa)

Ayahuasca

• Dating My Ayahuasca Shaman: Sex, Power, and Consent (Chacruna)

• Women’s Historical Influence on “Set and Setting” (Chacruna)

Iboga

• In Defending Hunter, Biden Showed Us His Potential (Rolling Stone)

• Why Ibogaine Is Not the Answer to the Opioid Crisis (Chacruna)

Synthetic Cannabinoids

• Crystal Structure of CB1 and MDMB-Fubinaca Gives Insight Into Synthetic Cannabinoids’ Potency (Psychedelic Science Review)

Ketamine

• Statement on Ketamine Sedation and Law Enforcement from the American College of Medical Toxicology (PR Web)

• Study reveals how subanesthetic ketamine is effective in treating adult amblyopia (News-Medical.net)

• A Dose of Ketamine Can Treat 'Lazy Eye' in Adults (Futurity)

Miscellaneous

• Psychedelic Gold Rush? Psilocybin Startup Compass Pathways Goes Public at More than $1B (DoubleBlind)

• Michigan Prosecutor Won’t Pursue Psychedelics Possession Cases Following Local Decriminalization Vote (Marijuana Moment)

• Decriminalize Nature Promotes New Oakland Initiative While Condemning Fellow Activists (Lucid News)

• Vermont Democratic Party Platform Calls For Decriminalizing Drugs And Legalizing Marijuana Sales (Marijuana Moment)

• Field Trip Psychedelics Inc. Announces Successful GLP Synthesis, Results From Initial Preclinical Testing for FT-104, its First Molecule in Development (PR Newswire)

• Psychedelics as a Catalyst for Existential Joy (Sam Woolfe)

• ‘The Word of God in a Molecule’: Turning to Psychedelics During a Pandemic (Bedford + Bowery)

• Did Early Christians Use Psychedelics? (The Daily Beast)

• Mydecine Innovations Group Announces The Official Mindleap Health Mobile App Launch in IOS and Android Stores Today (Psilocybin Alpha)

• Psychedelic-Assisted Therapy in the Post-Pandemic Era (Psychedelic Science Review)

• Psychedelic Industry 101: How to Get Involved (Reality Sandwich)

• The Systemic Culture Problems of the Psychedelics Industry (Lucid News)

• How I Used Psychedelics To Support My Sobriety (Yes, You Read That Right) (mindbodygreen)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 9.18.20

Cannabis

• House Postpones Vote On Bill To Federally Legalize Marijuana Until After Election (Marijuana Moment)

• These states are voting on cannabis legalization this November (CNN)

• Vermont Bill To Legalize Marijuana Sales One Step Away From Governor’s Desk After House Vote (Marijuana Moment)

• Vermont House Approves Marijuana Expungement And Decriminalization Expansion Bill (Marijuana Moment)

• How cannabis use impacted mental health during COVID (Cannabis Health News)

• Virginia House And Senate Approve Marijuana Expungement Bills (Marijuana Moment)

• NORML Files Amicus Brief to the Supreme Court Challenging Cannabis’ Schedule I Prohibited Status Under Federal Law (NORML)

• Nebraska Medical Marijuana Activists Will Pursue 2022 Ballot Measure After Court Blocks This Year’s Effort (Marijuana Moment)

• Cannabis Pilot Programs Are Sprouting in Europe (Cannabis Wire)

• Mississippi Medical Marijuana Ballot Language Threatens To Confuse Voters With Two Questions (Marijuana Moment)

• Cancard Will Effectively Decriminalise Medicinal Cannabis In The UK From November 1st (Seedsman)

• Policy Briefing: World Health Organisation Cannabis Rescheduling And Its Relevance For The Caribbean (TalkingDrugs)

• Slim Majority Of Arizona Voters Support Marijuana Legalization Ballot Measure, New Poll Finds (Marijuana Moment)

• Americans will spend $60 billion on illicit marijuana this year, report says (Leafly)

• USDA Approves Hemp Plans For Utah And Another Indian Tribe (Marijuana Moment)

• The Feds Are Funding a Study to See If Milk From Hemp-Eating Cows Will Get You High (MERRY JANE)

• Missouri Sends $2.1M In Medical Marijuana Revenue To Military Veterans Health Programs (Marijuana Moment)

• Cheap Cannabinoids That May Cure Cancer (Nanalyze)

LSD

• Scientists Uncover the Molecular Origins of an LSD Trip (Inverse)

• Figuring Out a Mouse-Sized Dose of LSD (Psychedelic Science Review)

• LSD Won’t Make a Good Painkiller (Pain News Network)

Magic Mushrooms

• Usona Puts New Psilocybin Synthesis Method in the Public Domain (Lucid News)

• First clinical trial launched to test psilocybin therapy for depression in cancer patients (News-Medical.net)

• Stopping a Too-Intense Mushroom Trip: Should You Even Try? (DoubleBlind)

MDMA

• Australians Are Lending Their Weight to Get Shrooms and MDMA Rescheduled (VICE)

Ayahuasca

• Legal Ayahuasca Churches Are Spreading Across Canada (VICE)

• Ayahuasca Makes you See, and Tobacco Makes You Dream (Chacruna)

• Ayahuasca Impacts the Big 5 Personality Traits (Psychedelic Science Review)

• A Woman Takes Ayahuasca and Discovers a Universal Truth (Patheos)

Peyote

• Indigenous Voices in Peyote Conservation: Preserving Medicine for Future Generations (Psychedelic Today)

Nitrous Oxide

• Aurora City Council Approves Temporary Ketamine Ban For First Responders (CBS Denver)

PCP

• Daniel Prude video initially withheld by Rochester police, documents show (Fox News)

Miscellaneous

• UC Berkeley launches new center for psychedelic science and education (Berkeley News)

• Can Psychedelics Treat Physical Illness? (DoubleBlind)

• Ann Arbor to consider decriminalizing psychoactive mushrooms, plants (Detroit Metro Times)

• Why Psychedelic Medicine Startups Are Poised To Get A Share Of Next Billion Dollar Market (PR Newswire)

• Compass Pathways Seeks $100 Million IPO For Psilocybin-Based Treatment (Seeking Alpha)

• How COVID-19 Has Impacted the Psychedelic Community (High Times)

• Why Set and Setting Matters for Microdosing (Medium)

• Compass Pathways IPO to Begin Trading 18th September on Nasdaq: CMPS (Psilocybin Alpha)

• Federal Workplace Drug Testing Proposal Could Discriminate Against People Of Color (Marijuana Moment)

• Women in the History of Psychedelic Plant Medicines (Chacruna)

• How Psychedelics Are Entering the Mainstream (Psychology Today)

• Could Group Therapy Make Psychedelic Drug Treatments More Accessible? (Forbes)

• IntelGenx inks double deals to develop oral film psychedelics for psychiatric use (Fierce Pharma)

• Expanded States of Consciousness for Healing and Growth (Chacruna)

• Red Light Holland’s Science and Innovation Division, Scarlette Lillie Joins Medical Psychedelics Working Group with Leading Academics; Professor David Nutt and Professor Jo Neill (Psilocybin Alpha)

• Conscious Parenting with Plant Medicine Allies (Reality Sandwich)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 7.31.20

Cannabis

• Congress Planning Vote On Federal Marijuana Legalization Bill In September, Sources Say (Marijuana Moment)

• Congress Votes To Protect Legal Marijuana (NORML)

• Democratic Party Delegates Reject Marijuana Legalization Amendment To 2020 Policy Platform (Marijuana Moment)

• Prescribed CBD could help people quit cannabis (Drug Science)

• Louisiana: Medical Cannabis Expansion Laws Take Effect (NORML)

• New York Senate Votes To Expunge Marijuana Convictions For More People (Marijuana Moment)

• New Jersey: Supermajority Back Legalization Measure Ahead of November Vote (NORML)

• Biden Proposes Federal Aid To Help States Expunge Marijuana Records (Marijuana Moment)

• Use of medicines mixed with marijuana allowed in local health promotion hospitals (The Nation Thailand)

• MD Judge: Cops Can’t Search You Because They Smell Weed (Filter)

• THC Microdosing Provides Pain Relief without Psychoactive Effects (Legal Reader)

• Navy Bans Hemp Shampoo For Sailors And Marines As Part Of Broader CBD Prohibition (Marijuana Moment)

• Survey: Many Employees Acknowledge Using Marijuana Immediately Following Their Pre-Employment Drug Test (NORML)

• First woman in Scotland prescribed cannabis legally after years of chronic pain (The Scotsman)

• Women Who Use Marijuana More Often Have Better Sex, Study Says (Marijuana Moment)

• Hedonism and Weed Leads to Happiness (Drug WarRant)

• Cannabis cravings: A new study addresses why it happens (Chicago Tribune)

• Cannabis lowers self reported headaches by nearly 50 percent (Drew Reports News)

LSD

• LSD Chemist William Leonard Pickard to be Released From Prison (Psymposia)

• How LSD is Made (DoubleBlind)

• Was Fleetwood Mac's Peter Green an Acid Casualty? (Celeb Stoner)

Magic Mushrooms

• Man Accused of Selling Mushrooms Faces Up to Twenty Years (Westword)

• Mindset Pharma Announces Filing of Groundbreaking Psilocybin Synthesis Patent (Psilocybin Alpha)

• Palliative Canadians await August 4th decision on psilocybin mushroom approval – TheraPsil urges Health Minister to ‘do the right thing’ (TheraPsil)

• Are magic mushroom edibles Canada’s next drug trend? (The GrowthOp)

• Shroom Expert Duo Releases 2020's First Psilocybin-Focused Cookbook Through Green Candy Press (Newsfile)

Ayahuasca

• Is Ayahuasca Cultural Heritage of Brazil? (Chacruna)

Novel Psychoactive Substances

• MindMed Completes Dosing 18-MC Phase 1 Study (Psilocybin Alpha)

• Crystal Structures of Hydrofumarate Salts of DMT Analogues EPT and MALT Solved (Psychedelic Science Review)

• Solved: The Crystal Structure of the Iodide Salts of DMPT and DMALT (Psychedelic Science Review)

Ketamine

• Ketamine May Help Treat MS-related Fatigue, Small Pilot Trial Suggests (Multiple Sclerosis News Today)

• Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO® (Psilocybin Alpha)

Datura

• Family poisoned in France after mistaking Hell's bells for spinach (CTV News)

Miscellaneous

• DC Officials Count Enough Valid Signatures To Put Psychedelics Decriminalization On Ballot, Activists Say (Marijuana Moment)

• Psychedelic drugs can greatly reduce psychiatric symptoms among special forces veterans, study finds (PsyPost)

• The Business Of Drugs: What Happened To Alexander Shulgin After The DEA Raid (Screen Rant)

• RIP Arnold Trebach, Who Helped Make Opposition to the Drug War Respectable (Reason)

• Empower Clinics Announces the Revocation of Cease Trade Order (Psilocybin Alpha)

• How Set and Setting Shape Psychedelic Cultures (Chacruna)

• Better living through chemistry? The CEO of Dr. Bronner’s wants to turn America on to drugs (Medium)

• The Psychedelic Picture Trip (Maps of the Mind)

• Novamind Closes the Acquisition of Cedar Psychiatry, a Leading Psychedelic Therapy Organization in the U.S. (Psilocybin Alpha)

• Are there Disadvantages to Microdosing Psychedelics? (DoubleBlind)

• New Psychedelic Online Conferences and Safe Spaces for People of Color (Chacruna)

• Ease restrictions on medical psychedelics to aid research, experts say (The Guardian)

• US Psychiatry Clinics Gear Up For New Psychedelic Treatments (Psilocybin Alpha)

• Entheos Foundation: Amadeus Diamond brings New Zealand psychedelic charity to life (Newshub)

• What It’s Like to Have Sex on Different Kinds of Psychedelics (DoubleBlind)

• Empower Clinics Reports Fiscal 2019 Results (Psilocybin Alpha)

• The Technodelic Augmented Reality of SoundSelf: Interview with Robin Arnott (Psychedelic Times)

• GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences (Psilocybin Alpha)

• Psychedelic Therapy Offers a Synergy of Biological, Psychosocial Interventions (Psychiatry and Behavioral Health Learning Network)

• Founders explain how microdosing on psychedelics has helped them spur new business ideas (Business Insider)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

Book Review - The Psychedelic Explorer's Guide

I have absorbed a lot of information concerning psychedelic substances during the past 13 years. Some sources took a scientific approach, full of statistics, surveys, and other assorted data. Others have focused on the spiritual use of these substances, which include direction for practices like meditation, yoga, and breathwork. There are also accounts of recreational use, which clearly illustrate the possibilities of both positive and negative outcomes of using and abusing these substances. I ate up as many books, movies, podcasts, YouTube clips, and audio lectures as I possibly could.

I also have my own experiences with several of these substances, and had already come to my personal opinion that they have the potential to awaken in me unexpected paths in my life, greater self-understanding, an ability to engage in self-healing, and a stronger connection with the Universe and the inhabitants of our planet that we call Earth.

Over the years, I learned a lot about psychedelics and often come noticed myself thinking to myself, "Oh, I've learned that already" while reading a book or watching a documentary. However, when I read James Fadiman's The Psychedelic Explorer's Guide: Safe, Therapeutic, and Sacred Journeys back in 2012 I found it to be the first work in quite a while that had so many new things to teach me. This book covers many aspects concerning psychedelic use that I was previously unaware of, such as the concept of sub-perceptual dosing and the importance of listening to non-vocal music such as Classical during the beginning of a psychedelic experience.

I first heard of this book from Lorenzo Hagerty's "Psychedelic Salon," a podcast that I have listened to since 2006. Fadiman is the guest on episode 302, during which Lorenzo interviews him about the book and his experience in the psychedelic research field. After hearing Fadiman speak about these things, I put the book on my "To-Read" list and purchased it a few months later. My intention when reading this book was to learn how to become a guide for others undergoing psychedelic experiences. I was pleasantly surprised by the wealth of information contained in the book afforded to those of us who wish to better integrate our psychedelic journeys into ordinary reality as well as learn to be a better guide to others. Following my reading of this book, I identified some aspects of my own psychedelic practice that I ended up changing in an effort to focus more on the therapeutic and spiritual uses of these substances, rather than my previous goal of just having a good time. While I still believe that the recreational use of these substances can have a positive outcome, this is the book that sold on the concept of using them in a more intelligent manner.

The Psychedelic Explorer’s Guide does a great job of dispelling some of the myths about psychedelics, offers a practical and positive itinerary for a successful experience, introduces several important people in this field, and does so in a way that is unbiased and helpful. It is important for the psychedelic community to have truth on its side, and Fadiman does an excellent job of collecting both scientific and anecdotal evidence and arranging it in a way that is easily understood. I commend him on his work and look forward to more coming from him in the near future.

5/5 stars. 352 pages.

Click here to buy the book.

Disclaimer: Think Wilder is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to amazon.com. I may earn a small commission for my endorsement, recommendation, testimonial, and/or link to any products or services from this website.

This Week in Psychedelics - 1.26.18

Image by Dahtamnay, courtesy of Creative Commons licensing.

Cannabis

• Vermont Becomes the Ninth State to Legalize Recreational Marijuana (Reason)
• Medical Cannabis Protections Extended As Part Of Short Term Federal Budget Agreement (NORML)
• What The Government Shutdown Means For Marijuana (NORML)
• Bipartisan Members Of Congress Speak Out Against AG Sessions (NORML)
• Why marijuana retailers can't use banks (The Economist)
• Washington DC's Cannabis Market Is Still Untested, Untaxed, and Underground (Leafly)
• What Is THCV (Tetrahydrocannabivarin) And What Does It Do? (High Times)
• New Jersey: New Governor Calls For 'Patients First' Expansion Of State's Medical Cannabis Access Program (NORML)
• Cannabis Stock Investors Should Pay Attention To The U.S. Federal Policy Change (Forbes)
• Ontario asks for public's opinion on allowing cannabis lounges as legalization looms (Global News)
• How a Cannabis Ban Turned One California County Into 'Ground Zero for Chaos' (Leafly)
• Poll Commissioned by Pot Prohibitionists Shows How Unpopular Pot Prohibition Is (Reason)
• Why No Gadget Can Prove How Stoned You Are (Wired)
• The PAX Era Ushers in a New Generation of Cannabis Cartridge Technology (Leafly)
• Most U.S. Attorneys in States With Legal Pot Don't Seem to Be Planning a Crackdown (Reason)
• Political Commentator Angela Rye on Ending Systematic Racism in the Marijuana Industry (ATTN:)
• Cannabis measures make headway in Indiana Legislature (WISH-TV)
• NORML Activists Take Marijuana Reform Fight to Harrisburg (NORML)
• A 9-Year-Old Accidentally Shared Her Grandpa's Marijuana Gummies With Her Fifth-Grade Class (TIME)
• Looking For Inspiring Work? Consider Cannabis Marketing. Here's Why. (Forbes)
• Re-criminalizing cannabis is worse than 1930s 'reefer madness': Guest opinion (The Oregonian)
• Leafly Readers Share Their Cleverest Hiding Places for a Cannabis Stash (Leafly)
• WeedMD Commences the Sale of Cannabis Oil (GlobeNewswire)
• 'Beyonce Takes THC': The Week in Cannabis Quotes (Leafly)
• Oregon's marijuana industry showcased at cannabis conference (KGW8)
• Getting to Know the Glossy Cannabis Lifestyle Magazines on the Market (Leafly)
• Canadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike: sources (Reuters)
• Introduction to Growing Cannabis with Aquaponics (Leafly)

LSD

• Microdosing LSD helped my company earn $10 million (New York Post)
• How to Microdose Acid and Magic Mushrooms? (Psychedelics Daily)

Psilocybin/Magic Mushrooms

• Psychedelic mushrooms reduce authoritarianism and boost nature relatedness, experimental study suggests (PsyPost)
• Psilocybin (from magic mushrooms) plus meditation and spiritual training leads to lasting changes in positive traits (Research Digest)
• Psychedelic Mushrooms Is the Potential Anti-depressant Treatment of the Future (Health Aim)
• New Psilocybin Research Suggests 'Set and Setting' Are Crucial to Helping Patients Get Better (Reason)

MDMA/Ecstasy

• The psychedelic renaissance: Can Ecstasy really be used to treat mental illness? (International Business Times)
• MDMA For PTSD Therapy Enters Final Round of Trials, Could Be Approved In U.S. and Canada By 2021 (Newsweek)
• From "X" to Rx: Discussing MDMA with Rick Doblin (Psychedelic Frontier)
• Psychedelic-Psychotherapy-QuickFacts (National Post)
• Fake ambulance worker exposed when teenager died from ecstasy at illegal rave (Metro)
• MDMA is Vipassana (Disinfo)
• Grieving mother, 50, whose daughter, 22, died after taking ecstasy in a 'final fling' to celebrate finishing her exams collects her maths degree in moving ceremony just months after her death (Daily Mail)

Ayahuasca/DMT

• No reason to believe the pineal gland alters consciousness by secreting DMT, psychedelic researcher says (PsyPost)
• Acute antidepressant effect of ayahuasca in juvenile non-human primate model of depression. (bioRxiv)

Synthetic Cannabinoids/Psychoactive Research Chemicals

• 'MDMA' warning after 8 Thanet men taken to hospital - with one said to be in a serious condition (The Isle of Thanet News)

Dissociatives

• Can Ketamine Improve 'Electroshock' Therapy? (The Fix)
• Ketamine could prove useful in treatment of severe social anxiety (PsyPost)
• Ketamine 'cures' suicidal woman of bipolar and severe depression (Metro)
• Man faces 5 years for sending PCP to Save the Children (CT Post)

Opiates/Opioids

• Why some US cities are opening safe spaces for injecting heroin (Vox)
• Tom Petty Died of an Accidental Drug Overdose, Coroner Says (TIME)
• Study of Postsurgical Patients Shows Addiction to Pain Pills Is Rare (Reason)
• Scripps researcher developing vaccine to battle heroin addiction (Chron)
• Philadelphia's Government 'Expresses Interest' in Safe Injection Sites (Reason)
• Opium cultivation down by 40%, narcotics chief says (The Nation)
• Chinese Drugmakers Are Getting Opioids Into the U.S. Through the Postal Service (TIME)
• The Feds Are Willing to Let More Medical Workers Treat Opioid Addicts. Now the States Need to Step Up and Allow It. (Reason)

Kratom

• Effective Ways To Deal With Kratom Constipation (Kratom Guides)
• FDA Warns Promoters of Herbal Addiction Treatments (Pain News Network) 
• Kratom: Libertarian Party of Colorado Rips Denver Human Use Ban (Westword)
• The Controversial Painkiller Known As Kratom (TG Daily)
• Kratom: substitute for opioids? (KOLO)

Kava

• 'Acute pain, sore muscles, anxiety, and lethargy': Athletes are embracing kava as an alternative to everything from supplements to opioids (Daily Mail)
• Farmers Keep Potential Buyers At Bay So Yaqona Plants Can Mature Properly (Fiji Sun)
• Kava maker brings popular Polynesian health drink to America (Daily Mail)

Khat

• What Is Khat? (High Times)
• Chewing khat leaves increases risk for chronic liver disease (Healio)
• UK Khat Ban Fails To Stop Contraband Imports (High Times)

Miscellaneous Psychedelics/Psychoactives/Drug Policy

• Your Sloppy Bitcoin Drug Deals Will Haunt You For Years (Wired)
• A psychedelic trip could tackle depression in a way that antidepressants can't (Business Insider)
• The Experience Elicited by Hallucinogens Presents the Highest Similarity to Dreaming within a Large Database of Psychoactive Substance Reports (Frontiers in Neuroscience)
• Cryptocurrency and Psychedelics: Interview with Brian Normand of Psymposia (Psychedelic Times)
• We Ate the Acid: A Note on Psychedelic Imagery (The Oak Tree Review)
• Trump's 24-year-old drug policy appointee was let go at law firm after he 'just didn't show' (The Washington Post)
• The Office of National Drug Control Policy Is on the Chopping Block Again. Here's Why That's Not a Bad Thing (Reason)
• Herbal Supplements May Be Dangerous When You Take Certain Prescription Drugs (TIME)
• How to Use TripSit's 'Guide to Drug Combinations' Chart (Psychedelic Times)
• Building a Modern Eleusis (Reality Sandwich)
• Bill aims to introduce driver drug testing for MDMA, cannabis and methamphetamine (Stuff.co.nz)
• Group urges safe use of psychedelic substances (The Kingston Whig-Standard)

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.